Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.31 |
| ▸ | CA2 | P00918 | 3/20 | 0.31 |
| ▸ | CA4 | P22748 | 2/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA7 | P43166 | 1/20 | 0.31 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1358916 | 0.83 | CA1 (0.33) | CA1CA2CA4CA12CA7 | |
| SCHEMBL3721700 | 0.73 | — | — | |
| SCHEMBL5701891 | 0.72 | RAPGEF4 (0.33) | CA1CA12 | |
| SCHEMBL5701821 | 0.72 | CA1 (0.33) | CA1CA2CA4CA12CA7 | |
| Tetramethylammonium Ion SCHEMBL27610804 | 0.71 | CA1 (0.36) | CA1CA2CA4CA12CA7 | |
| SCHEMBL7702552 | 0.69 | CA1 (0.43) | CA1CA2CA4CA12CA7 | |
| SCHEMBL41646 | 0.69 | CA1 (0.43) | CA1CA2CA4CA12CA7 | |
| SCHEMBL5637066 | 0.68 | TSHR (0.35) | — | |
| SCHEMBL7607898 | 0.68 | — | — | |
| Methyl Alcohol SCHEMBL27510918 | 0.67 | CA1 (0.43) | CA1CA2CA4CA12CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8507707-B2 | Regioselective catalytic conversion of hydrocarbons to versatile synthetic reagents via C-H bond functionalization | UNIVERSITY OF WINDSOR (CA) | 2013-08-13 | — | — | US | disclosed |
| US-20110282087-A1 | Regioselective catalytic conversion of hydrocarbons to versatile synthetic reagents via C-H bond functionalization | UNIVERSITY OF WINDSOR (CA) | 2011-11-17 | — | — | US | disclosed |
| US-RE39679-E1 | Substituted heterocycle fused gamma-carbolines | BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) | 2007-06-05 | — | — | US | disclosed |
| US-6713471-B1 | SUCH AS TERT-BUTYL-1-METHYL-6,7,9,12-TETRAHYDRO-5H-PYRIDO-(4,3-B)(1,4) THIAZEPINO(2,3,4-HI)INDOLE-11(10H)-CARBOXYLATE; SEROTONIN AGONISTS AND ANTAGONISTS; CENTRAL NERVOUS SYSTEM DISORDERS | BRISTOL-MYERS SQUIBB PHARMA COMPANY | 2004-03-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110282087-A1 | Regioselective catalytic conversion of hydrocarbons to versatile synthetic reagents via C-H bond functionalization | AHR, HRH4, HRH3 | CA1 1417/4885CA2 2457/4885CA4 297/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.